Zhengye Biotechnology Holding Limited (ZYBT)

ZYBT Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	50.33	18.6	15.07	9.75	6.28
Short-Term Investments	1.56	1.43	1.22	-	-
Cash & Short-Term Investments	51.89	20.04	16.3	9.75	6.28
Cash Growth	158.98%	22.95%	67.22%	55.09%	-
Accounts Receivable	18.49	85.16	97.38	133.58	101.47
Other Receivables	-	0.74	2.04	0.67	0.72
Receivables	18.49	85.89	99.42	134.25	102.19
Inventory	39.17	58.22	58.3	55.42	43.62
Prepaid Expenses	16.38	-	-	-	-
Restricted Cash	0	0	12.11	-	-
Other Current Assets	11.5	13.41	3.11	2.43	1.71
Total Current Assets	137.42	177.57	189.24	214.31	164.94
Property, Plant & Equipment	237.28	255.16	263.25	275.23	246.41
Other Intangible Assets	54.76	22.78	24.48	27.9	20.75
Long-Term Deferred Tax Assets	-	10.99	11.91	-	-
Long-Term Deferred Charges	-	8.05	4.5	-	-
Other Long-Term Assets	7.01	18.7	6.5	2.23	13.17
Total Assets	436.47	493.25	499.89	519.67	445.28

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	44.01	42.96	45.66	79.28	77.57
Accrued Expenses	0.65	0.8	0.54	0.57	0.6
Short-Term Debt	65.1	74.59	79.86	54.89	30
Current Portion of Long-Term Debt	0.7	7.19	-	-	-
Current Portion of Leases	0.11	-	-	-	-
Current Income Taxes Payable	2.35	2.07	2.3	10	6.81
Current Unearned Revenue	4.83	3.69	3.99	4.7	4.28
Other Current Liabilities	2.74	4.62	17.9	2.79	6.37
Total Current Liabilities	120.48	135.91	150.23	152.23	125.63
Long-Term Debt	8.85	4.8	9.99	9.99	-
Long-Term Leases	0.33	-	-	-	-
Long-Term Deferred Tax Liabilities	0.1	-	-	-	-
Other Long-Term Liabilities	-	-	0.39	0.59	0.82
Total Liabilities	129.76	140.71	160.62	162.81	126.44

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	240.75	203.15	203.15	203.15	203.15
Retained Earnings	11.01	80.8	69.69	93.34	64.32
Comprehensive Income & Other	-1.93	0	-	-	-
Total Common Equity	249.85	283.96	272.85	296.5	267.47
Minority Interest	56.87	68.58	66.42	60.37	51.36
Shareholders' Equity	306.72	352.54	339.27	356.87	318.84
Total Liabilities & Equity	436.47	493.25	499.89	519.67	445.28

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	75.08	86.58	89.85	64.88	30
Net Cash (Debt)	-23.19	-66.54	-73.55	-55.13	-23.72
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.49	-1.46	-1.61	-1.21	-0.52
Filing Date Shares Outstanding	47.39	47.39	45.67	45.67	45.67
Total Common Shares Outstanding	47.39	45.67	45.67	45.67	45.67
Working Capital	16.94	41.66	39.01	62.08	39.32
Book Value Per Share	5.27	6.22	5.97	6.49	5.86
Tangible Book Value	195.09	261.18	248.37	268.59	246.72
Tangible Book Value Per Share	4.12	5.72	5.44	5.88	5.40
Buildings	217.14	205.43	197.19	119.79	166.9
Machinery	150.84	151.54	151.04	146.74	118
Construction In Progress	0.61	9.75	7.62	82.06	52.76

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 28, 2026

Data Sources Report a data error